跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
influenza + coronavirus vaccine
首页
药物
influenza + coronavirus vaccine
influenza + coronavirus vaccine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Influenza-coronavirus combination vaccine
申请人: MODERNA THERAPEUTICS INC
优先权: 2021
CN
Combination vaccine against coronavirus and influenza virus
申请人: NANJING AOLUO BIOTECHNOLOGY CO LTD
优先权: 2023
CN
COMBINATION VACCINE FOR PREVENTION OF INFLUENZA AND CORONAVIRUS INFECTIONS
申请人: UNIV HOKKAIDO NAT UNIV CORP
优先权: 2023
CN
EP
US
WO
4 件公开
Dual nucleic acid vaccine for coronavirus and influenza virus
申请人: INST MILITARY MEDICINE ACADEMY MILITARY SCIENCES PLA
优先权: 2021
CN
Universal influenza virus and coronavirus combined polypeptide and application of vaccine of universal influenza virus and coronavirus combined polypeptide
申请人: INST FOR VIRAL DISEASE CONTROL AND PREVENTION CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION
优先权: 2022
CN
COMBINATION VACCINES AGAINST CORONAVIRUS INFECTION, INFLUENZA INFECTION, AND/OR RSV INFECTION
申请人: BIONTECH SE
优先权: 2022
CN
EP
US
WO
4 件公开
MRNA-based combined vaccine against coronavirus and influenza virus and preparation method of mRNA-based combined vaccine
申请人: JIACHEN XIHAI HANGZHOU BIOTECHNOLOGY CO LTD
优先权: 2020
CN
Influenza virus, novel coronavirus and respiratory syncytial virus triple vaccine and preparation method thereof
申请人: THE FIRST MEDICAL CENTER OF CHINESE PLA GENERAL HOSPITAL
优先权: 2022
CN
药物
反馈